cui1,cui2,relation,name1,name2,type1,type2,weight,predicate
C0001551,C0006826,ASSOCIATED_WITH,Immunologic Adjuvants,Malignant Neoplasms,imft,neop,1,ASSOCIATED_WITH_IMFTaswtNEOP
C0001551,C0007097,ASSOCIATED_WITH,Immunologic Adjuvants,Carcinoma,imft,neop,1,ASSOCIATED_WITH_IMFTaswtNEOP
C0001551,C0007131,ASSOCIATED_WITH,Immunologic Adjuvants,Non-Small Cell Lung Carcinoma,imft,neop,1,ASSOCIATED_WITH_IMFTaswtNEOP
C0001551,C0027651,ASSOCIATED_WITH,Immunologic Adjuvants,Neoplasms,imft,neop,2,ASSOCIATED_WITH_IMFTaswtNEOP
C0001551,C1261473,ASSOCIATED_WITH,Immunologic Adjuvants,Sarcoma,imft,neop,1,ASSOCIATED_WITH_IMFTaswtNEOP
C0002092,C0007847,ASSOCIATED_WITH,Allergens,Malignant tumor of cervix,imft,neop,1,ASSOCIATED_WITH_IMFTaswtNEOP
C0002092,C0206695,ASSOCIATED_WITH,Allergens,"Carcinoma, Neuroendocrine",imft,neop,1,ASSOCIATED_WITH_IMFTaswtNEOP
C0002092,C0242379,ASSOCIATED_WITH,Allergens,Malignant neoplasm of lung,imft,neop,1,ASSOCIATED_WITH_IMFTaswtNEOP
C0003316,C0006826,ASSOCIATED_WITH,Epitopes,Malignant Neoplasms,imft,neop,2,ASSOCIATED_WITH_IMFTaswtNEOP
C0003316,C0027627,ASSOCIATED_WITH,Epitopes,Neoplasm Metastasis,imft,neop,1,ASSOCIATED_WITH_IMFTaswtNEOP
C0003316,C0027651,ASSOCIATED_WITH,Epitopes,Neoplasms,imft,neop,1,ASSOCIATED_WITH_IMFTaswtNEOP
C0003320,C0006826,ASSOCIATED_WITH,Antigens,Malignant Neoplasms,imft,neop,7,ASSOCIATED_WITH_IMFTaswtNEOP
C0003320,C0023418,ASSOCIATED_WITH,Antigens,leukemia,imft,neop,1,ASSOCIATED_WITH_IMFTaswtNEOP
C0003320,C0023467,ASSOCIATED_WITH,Antigens,"Leukemia, Myelocytic, Acute",imft,neop,1,ASSOCIATED_WITH_IMFTaswtNEOP
C0003320,C0023903,ASSOCIATED_WITH,Antigens,Liver neoplasms,imft,neop,1,ASSOCIATED_WITH_IMFTaswtNEOP
C0003320,C0024299,ASSOCIATED_WITH,Antigens,Lymphoma,imft,neop,1,ASSOCIATED_WITH_IMFTaswtNEOP
C0003320,C0027651,ASSOCIATED_WITH,Antigens,Neoplasms,imft,neop,3,ASSOCIATED_WITH_IMFTaswtNEOP
C0003320,C0032580,ASSOCIATED_WITH,Antigens,Adenomatous Polyposis Coli,imft,neop,1,ASSOCIATED_WITH_IMFTaswtNEOP
C0003320,C0032927,ASSOCIATED_WITH,Antigens,Precancerous Conditions,imft,neop,1,ASSOCIATED_WITH_IMFTaswtNEOP
C0003320,C0206698,ASSOCIATED_WITH,Antigens,Cholangiocarcinoma,imft,neop,1,ASSOCIATED_WITH_IMFTaswtNEOP
C0003320,C0206743,ASSOCIATED_WITH,Antigens,Rhabdoid Tumor,imft,neop,2,ASSOCIATED_WITH_IMFTaswtNEOP
C0003320,C0242647,ASSOCIATED_WITH,Antigens,Mucosa-Associated Lymphoid Tissue Lymphoma,imft,neop,1,ASSOCIATED_WITH_IMFTaswtNEOP
C0003320,C0260037,ASSOCIATED_WITH,Antigens,Multiple tumors,imft,neop,1,ASSOCIATED_WITH_IMFTaswtNEOP
C0003320,C0276491,ASSOCIATED_WITH,Antigens,Mouse mammary tumor virus infection,imft,neop,1,ASSOCIATED_WITH_IMFTaswtNEOP
C0003320,C0280100,ASSOCIATED_WITH,Antigens,Solid Neoplasm,imft,neop,1,ASSOCIATED_WITH_IMFTaswtNEOP
C0003320,C0280803,ASSOCIATED_WITH,Antigens,Primary central nervous system lymphoma,imft,neop,1,ASSOCIATED_WITH_IMFTaswtNEOP
C0003320,C0349530,ASSOCIATED_WITH,Antigens,Early gastric cancer,imft,neop,1,ASSOCIATED_WITH_IMFTaswtNEOP
C0003320,C0432487,ASSOCIATED_WITH,Antigens,Post-transplant lymphoproliferative disorder,imft,neop,1,ASSOCIATED_WITH_IMFTaswtNEOP
C0003320,C4553239,ASSOCIATED_WITH,Antigens,Stage II Prostate Cancer AJCC v8,imft,neop,1,ASSOCIATED_WITH_IMFTaswtNEOP
C0003335,C0006142,ASSOCIATED_WITH,"Antigens, Neoplasm",Malignant neoplasm of breast,imft,neop,1,ASSOCIATED_WITH_IMFTaswtNEOP
C0003335,C0027651,ASSOCIATED_WITH,"Antigens, Neoplasm",Neoplasms,imft,neop,2,ASSOCIATED_WITH_IMFTaswtNEOP
C0003335,C0280100,ASSOCIATED_WITH,"Antigens, Neoplasm",Solid Neoplasm,imft,neop,1,ASSOCIATED_WITH_IMFTaswtNEOP
C0003335,C0920616,ASSOCIATED_WITH,"Antigens, Neoplasm",neoplasm regression,imft,neop,1,ASSOCIATED_WITH_IMFTaswtNEOP
C0003339,C0023418,ASSOCIATED_WITH,Surface Antigens,leukemia,imft,neop,1,ASSOCIATED_WITH_IMFTaswtNEOP
C0003339,C2239176,ASSOCIATED_WITH,Surface Antigens,Liver carcinoma,imft,neop,1,ASSOCIATED_WITH_IMFTaswtNEOP
C0003342,C0014522,ASSOCIATED_WITH,"Antigens, Viral",Epidermodysplasia Verruciformis,imft,neop,1,ASSOCIATED_WITH_IMFTaswtNEOP
C0004359,C0006826,ASSOCIATED_WITH,Autoantigens,Malignant Neoplasms,imft,neop,1,ASSOCIATED_WITH_IMFTaswtNEOP
C0004359,C0030472,ASSOCIATED_WITH,Autoantigens,Paraneoplastic Syndromes,imft,neop,1,ASSOCIATED_WITH_IMFTaswtNEOP
C0004359,C0242379,ASSOCIATED_WITH,Autoantigens,Malignant neoplasm of lung,imft,neop,1,ASSOCIATED_WITH_IMFTaswtNEOP
C0005525,C0006826,ASSOCIATED_WITH,Biological Response Modifiers,Malignant Neoplasms,imft,neop,7,ASSOCIATED_WITH_IMFTaswtNEOP
C0005525,C0007131,ASSOCIATED_WITH,Biological Response Modifiers,Non-Small Cell Lung Carcinoma,imft,neop,3,ASSOCIATED_WITH_IMFTaswtNEOP
C0005525,C0009402,ASSOCIATED_WITH,Biological Response Modifiers,Colorectal Carcinoma,imft,neop,1,ASSOCIATED_WITH_IMFTaswtNEOP
C0005525,C0024305,ASSOCIATED_WITH,Biological Response Modifiers,"Lymphoma, Non-Hodgkin",imft,neop,1,ASSOCIATED_WITH_IMFTaswtNEOP
C0005525,C0024314,ASSOCIATED_WITH,Biological Response Modifiers,Lymphoproliferative Disorders,imft,neop,1,ASSOCIATED_WITH_IMFTaswtNEOP
C0005525,C0025202,ASSOCIATED_WITH,Biological Response Modifiers,melanoma,imft,neop,1,ASSOCIATED_WITH_IMFTaswtNEOP
C0005525,C0026764,ASSOCIATED_WITH,Biological Response Modifiers,Multiple Myeloma,imft,neop,1,ASSOCIATED_WITH_IMFTaswtNEOP
C0005525,C0027651,ASSOCIATED_WITH,Biological Response Modifiers,Neoplasms,imft,neop,2,ASSOCIATED_WITH_IMFTaswtNEOP
C0005525,C0079774,ASSOCIATED_WITH,Biological Response Modifiers,Peripheral T-Cell Lymphoma,imft,neop,1,ASSOCIATED_WITH_IMFTaswtNEOP
C0005525,C0242379,ASSOCIATED_WITH,Biological Response Modifiers,Malignant neoplasm of lung,imft,neop,1,ASSOCIATED_WITH_IMFTaswtNEOP
C0005525,C0278987,ASSOCIATED_WITH,Biological Response Modifiers,Metastatic non-small cell lung cancer,imft,neop,1,ASSOCIATED_WITH_IMFTaswtNEOP
C0005525,C0279702,ASSOCIATED_WITH,Biological Response Modifiers,Conventional (Clear Cell) Renal Cell Carcinoma,imft,neop,1,ASSOCIATED_WITH_IMFTaswtNEOP
C0005525,C0280100,ASSOCIATED_WITH,Biological Response Modifiers,Solid Neoplasm,imft,neop,1,ASSOCIATED_WITH_IMFTaswtNEOP
C0005525,C0346429,ASSOCIATED_WITH,Biological Response Modifiers,Multiple malignancy,imft,neop,1,ASSOCIATED_WITH_IMFTaswtNEOP
C0005525,C4725682,ASSOCIATED_WITH,Biological Response Modifiers,Platinum-Resistant Urothelial Carcinoma,imft,neop,1,ASSOCIATED_WITH_IMFTaswtNEOP
C0005525,C4727088,ASSOCIATED_WITH,Biological Response Modifiers,Advanced Lung Carcinoma,imft,neop,1,ASSOCIATED_WITH_IMFTaswtNEOP
C0006613,C0009402,ASSOCIATED_WITH,CA-19-9 Antigen,Colorectal Carcinoma,imft,neop,1,ASSOCIATED_WITH_IMFTaswtNEOP
C0018593,C0027627,ASSOCIATED_WITH,Haptens,Neoplasm Metastasis,imft,neop,1,ASSOCIATED_WITH_IMFTaswtNEOP
C0019168,C0023418,ASSOCIATED_WITH,Hepatitis B Surface Antigens,leukemia,imft,neop,1,ASSOCIATED_WITH_IMFTaswtNEOP
C0019168,C2239176,ASSOCIATED_WITH,Hepatitis B Surface Antigens,Liver carcinoma,imft,neop,1,ASSOCIATED_WITH_IMFTaswtNEOP
C0021054,C0025202,ASSOCIATED_WITH,Immunologic Factors,melanoma,imft,neop,1,ASSOCIATED_WITH_IMFTaswtNEOP
C0021081,C0006826,ASSOCIATED_WITH,Immunosuppressive Agents,Malignant Neoplasms,imft,neop,2,ASSOCIATED_WITH_IMFTaswtNEOP
C0021081,C0017638,ASSOCIATED_WITH,Immunosuppressive Agents,Glioma,imft,neop,1,ASSOCIATED_WITH_IMFTaswtNEOP
C0034496,C0016057,ASSOCIATED_WITH,Rabies Vaccines,Fibrosarcoma,imft,neop,1,ASSOCIATED_WITH_IMFTaswtNEOP
C0040673,C0006826,ASSOCIATED_WITH,Transfer Factor,Malignant Neoplasms,imft,neop,1,ASSOCIATED_WITH_IMFTaswtNEOP
C0042212,C0027651,ASSOCIATED_WITH,"Vaccines, Inactivated",Neoplasms,imft,neop,1,ASSOCIATED_WITH_IMFTaswtNEOP
C0042212,C4553253,ASSOCIATED_WITH,"Vaccines, Inactivated",Stage IIA Prostate Cancer AJCC v8,imft,neop,1,ASSOCIATED_WITH_IMFTaswtNEOP
C0057317,C0206655,ASSOCIATED_WITH,Hepatitis delta Antigens,Alveolar rhabdomyosarcoma,imft,neop,1,ASSOCIATED_WITH_IMFTaswtNEOP
C0058218,C0027627,ASSOCIATED_WITH,dimethyl fumarate,Neoplasm Metastasis,imft,neop,1,ASSOCIATED_WITH_IMFTaswtNEOP
C0206253,C0343079,ASSOCIATED_WITH,"Vaccines, Combined","Milia, Multiple Eruptive",imft,neop,1,ASSOCIATED_WITH_IMFTaswtNEOP
C0243019,C0027651,ASSOCIATED_WITH,Radioimmunoconjugates,Neoplasms,imft,neop,1,ASSOCIATED_WITH_IMFTaswtNEOP
C0282580,C1531608,ASSOCIATED_WITH,"Epitopes, T-Lymphocyte",Smoldering myeloma,imft,neop,1,ASSOCIATED_WITH_IMFTaswtNEOP
C0282581,C0027627,ASSOCIATED_WITH,"Epitopes, B-Lymphocyte",Neoplasm Metastasis,imft,neop,1,ASSOCIATED_WITH_IMFTaswtNEOP
C0298751,C0006826,ASSOCIATED_WITH,Lewis Y antigen,Malignant Neoplasms,imft,neop,1,ASSOCIATED_WITH_IMFTaswtNEOP
C0443758,C0007124,ASSOCIATED_WITH,Carbohydrate antigen,Noninfiltrating Intraductal Carcinoma,imft,neop,1,ASSOCIATED_WITH_IMFTaswtNEOP
C0443758,C1368683,ASSOCIATED_WITH,Carbohydrate antigen,Epithelioma,imft,neop,1,ASSOCIATED_WITH_IMFTaswtNEOP
C0598658,C1333064,ASSOCIATED_WITH,antibody conjugate,Classical Hodgkin's Lymphoma,imft,neop,2,ASSOCIATED_WITH_IMFTaswtNEOP
C0599934,C0006826,ASSOCIATED_WITH,"Vaccines, Peptide",Malignant Neoplasms,imft,neop,2,ASSOCIATED_WITH_IMFTaswtNEOP
C0907160,C1266129,ASSOCIATED_WITH,Pegylated Interferon Alfa,Atypical Lipoma,imft,neop,1,ASSOCIATED_WITH_IMFTaswtNEOP
C1135133,C0376358,ASSOCIATED_WITH,Provenge,Malignant neoplasm of prostate,imft,neop,1,ASSOCIATED_WITH_IMFTaswtNEOP
C1440511,C0343079,ASSOCIATED_WITH,Coxsackievirus B1,"Milia, Multiple Eruptive",imft,neop,1,ASSOCIATED_WITH_IMFTaswtNEOP
C1441165,C0205945,ASSOCIATED_WITH,S-100,"Sarcoma, Spindle Cell",imft,neop,1,ASSOCIATED_WITH_IMFTaswtNEOP
C1441165,C0751690,ASSOCIATED_WITH,S-100,Malignant Peripheral Nerve Sheath Tumor,imft,neop,1,ASSOCIATED_WITH_IMFTaswtNEOP
C1443014,C0206630,ASSOCIATED_WITH,Dog antigen,Endometrial Stromal Sarcoma,imft,neop,1,ASSOCIATED_WITH_IMFTaswtNEOP
C1511767,C0376358,ASSOCIATED_WITH,Dendritic Cell Vaccine,Malignant neoplasm of prostate,imft,neop,1,ASSOCIATED_WITH_IMFTaswtNEOP
C1579313,C0005684,ASSOCIATED_WITH,IMMUNE STIMULANTS,Malignant neoplasm of urinary bladder,imft,neop,1,ASSOCIATED_WITH_IMFTaswtNEOP
C1721787,C0007847,ASSOCIATED_WITH,Gardasil,Malignant tumor of cervix,imft,neop,1,ASSOCIATED_WITH_IMFTaswtNEOP
C1721789,C0007847,ASSOCIATED_WITH,Cervarix,Malignant tumor of cervix,imft,neop,1,ASSOCIATED_WITH_IMFTaswtNEOP
C2240392,C0220630,ASSOCIATED_WITH,Hepatitis B Vaccines,Adult Liver Carcinoma,imft,neop,1,ASSOCIATED_WITH_IMFTaswtNEOP
C2352839,C0006826,ASSOCIATED_WITH,sialyl Lewis X antigen,Malignant Neoplasms,imft,neop,1,ASSOCIATED_WITH_IMFTaswtNEOP
C2352839,C0007102,ASSOCIATED_WITH,sialyl Lewis X antigen,Malignant tumor of colon,imft,neop,1,ASSOCIATED_WITH_IMFTaswtNEOP
C2352839,C0686619,ASSOCIATED_WITH,sialyl Lewis X antigen,Secondary malignant neoplasm of lymph node,imft,neop,1,ASSOCIATED_WITH_IMFTaswtNEOP
C2352839,C1334274,ASSOCIATED_WITH,sialyl Lewis X antigen,Invasive Carcinoma,imft,neop,1,ASSOCIATED_WITH_IMFTaswtNEOP
C2599731,C0001418,ASSOCIATED_WITH,Cytomegalovirus immediate-early Ag,Adenocarcinoma,imft,neop,1,ASSOCIATED_WITH_IMFTaswtNEOP
C2708569,C0007102,ASSOCIATED_WITH,S little d super little a Ag,Malignant tumor of colon,imft,neop,1,ASSOCIATED_WITH_IMFTaswtNEOP
C3827136,C0007131,ASSOCIATED_WITH,CV9202,Non-Small Cell Lung Carcinoma,imft,neop,1,ASSOCIATED_WITH_IMFTaswtNEOP
C4552025,C0027651,ASSOCIATED_WITH,Thymidine Kinase (-) Vaccinia-GM-CSF JX-594 Vaccine,Neoplasms,imft,neop,1,ASSOCIATED_WITH_IMFTaswtNEOP
C4684977,C0006826,ASSOCIATED_WITH,Immune Checkpoint Inhibitor,Malignant Neoplasms,imft,neop,3,ASSOCIATED_WITH_IMFTaswtNEOP
C4684977,C0027651,ASSOCIATED_WITH,Immune Checkpoint Inhibitor,Neoplasms,imft,neop,2,ASSOCIATED_WITH_IMFTaswtNEOP
C4684977,C0242379,ASSOCIATED_WITH,Immune Checkpoint Inhibitor,Malignant neoplasm of lung,imft,neop,1,ASSOCIATED_WITH_IMFTaswtNEOP
C4684977,C2239176,ASSOCIATED_WITH,Immune Checkpoint Inhibitor,Liver carcinoma,imft,neop,1,ASSOCIATED_WITH_IMFTaswtNEOP
C4684977,C4544822,ASSOCIATED_WITH,Immune Checkpoint Inhibitor,Microsatellite instability-high colorectal cancer,imft,neop,1,ASSOCIATED_WITH_IMFTaswtNEOP
